GCAT Data Access
GCAT Data Access
1. ACCES MANIFEST
The GCAT project has a firm commitment to the participants and researchers to establish develop and promote research in health and wellbeing for society.
The GCAT samples and data can be used for biomedical research by universities and public institutions and profit and non-profit-making private companies. The shared use of the biological samples is one of the objectives of the GCAT.
Because of the limited nature of the samples and the strategic nature of the associated information, which is its principal added value, access and transmission will be controlled by specific committees (Executive Committee and Evaluation Committees).
Access requires the following criteria to be fulfilled:
The GCAT publishes its policy and procedures for access to the samples and data and their use in research.
The GCAT will maintain total control over access and use of data and samples in the project in accordance with its commitment to public use of the collection and with the framework of its own regulations.
The Executive Committee of the GCAT will constantly revise the policy of use of the collection to ensure it complies with the access policy and to ensure that the resource is used for the public benefit.
- Acceptance of GCAT Policy of Use
Access will be defined in the terms and conditions established and accepted by the GCAT participants, including the fulfillment of the consent granted.
- Research within GCAT Strategic Lines
The projects will fit within the scientific objectives of the GCAT Project.
Access to the data and/or samples will be granted after a scientific and ethical examination of the research.
All the proposals will be evaluated by the relevant committees (scientific and ethical) to ensure that they are consistent with the consent of the participants, that they have the pertinent ethical approval and that they are up to the desired standards of excellence. While the resource is being developed, the first data and samples will be used to validate and improve the methodology for compilation of data and analyses.
A quota will be charged for access, with the possibility of higher charges for organizations which could be expected to make a profit from the use of the resource.
- Protection of Intellectual Property
Access and transmission of data implies and acceptance of the intellectual property, both that generated by GCAT and that produced by the researcher.
- Protection of Confidentiality
The samples and data together accessible by the public will always be transmitted in an anonymized form.
- Sole Procedure
The GCAT has established a global policy and the detailed conditions of access that have been, and will continue to be, developed with equality, transparency of decision-making and management of conflicts of interest and the prioritization of the use of the samples.
The GCAT makes this commitment explicit with the observance of and adherence to a legal and ethical framework for action for all the ethical, legal and social aspects (ELSI) implied by or derived from the activity of the GCAT Project.
This is outlined in the document DOC-2-GCAT ELSI and DOC-9- Gestio cessions de mostres i dades GCAT (in Catalan), and summarized in the DOC-9- Annex 5 GCAT Data Acces.
2. ACCES PROCEDURE
REGISTRATION AND EVALUATION REQUEST
To confirm their identity, while maintaining confidentiality, each person that wants to use the GCAT resources must prove their identity before registering as authorized researchers. Information is requested to identify and contact the applicant; the information will be registered in the GCAT data base and will be used to manage future requests.
The Principal Researcher (PI) is required to complete an application form with the following information for his/her petition to be evaluated for availability.
- Brief summary (200 words or less) of the research project
- Overall data or samples necessary, quantity and types of sample with a brief justification
- Whether s/he has funding or must seek it
- Any doubt or question about the IMPPC-GCAT Biobank, its resources (eg. the data or samples available)
Once the availability is positively evaluated, the Principal Researcher (PI) should complete and sign the MTA / DTA agreement.